Long-Term Debt (Tables)

6 Months Ended

Sep. 08, 2018

Debt Disclosure [Abstract]

Long-Term Debt and Capital Lease Obligations

Our long-term debt consisted of the following:

	Average Interest Rate at September 8, 2018	Maturity Year	September 8, 2018			February 24, 2018
Secured Term Loan Facility - variable rate	5.58%	2024	$	698		$	834
Senior Notes - fixed rate	6.75%	2021	180			400
Senior Notes - fixed rate	7.75%	2022	350			350
Revolving ABL Credit Facility - variable rate	3.71%	2021	183			127
Other secured loans - variable rate	5.11%	2022-2023	39			48
Debt financing costs, net			(19		)	(24		)
Original issue discount on debt			(2		)	(3		)
Total debt			1,429			1,732
Less current maturities of long-term debt			(6		)	(8		)
Long-term debt			$	1,423		$	1,724

Secured Assets and Unused Available Credit and Fees, Revolving ABL Credit Facility

he assets included in the Condensed Consolidated Balance Sheets securing the outstanding borrowings under the Revolving ABL Credit Facility on a first-priority basis, and the unused available credit and fees under the Revolving ABL Credit Facility, were as follows:

Assets securing the Revolving ABL Credit Facility(1):	September 8, 2018		February 24, 2018
Certain inventory assets included in Inventories, net and Current assets of discontinued operations	$	1,286	$	1,176
Certain receivables included in Receivables, net and Current assets of discontinued operations	440		410
Certain amounts included in Cash and cash equivalents and Current assets of discontinued operations	16		20

(1) The Revolving ABL Credit Facility is also secured by all of our pharmacy scripts including those within Intangible assets, net.

Unused available credit and fees under the Revolving ABL Credit Facility:	September 8, 2018			February 24, 2018
Outstanding letters of credit	$	57		$	57
Letters of credit fees	1.375		%	1.375		%
Unused available credit	761			816
Unused facility fees	0.25		%	0.25		%